GlobeNewswire

Juniper Networks Becomes Global Sponsor of World Robot Olympiad

Dela

Global competition that enables tens of thousands of young people to develop invaluable automation and programming skills now includes Engineering Simplicity award

 

SUNNYVALE, Calif., June 18, 2018 (GLOBE NEWSWIRE) -- Juniper Networks (NYSE:JNPR), an industry leader in automated, scalable and secure networks, today announced that it has become the global technology partner of the World Robot Olympiad(TM) Association (WRO®), a non-profit organization that focuses on the hands-on development of robotics within STEM (Science, Technology, Engineering, Math) education on a worldwide scale. In a multi-year agreement, Juniper will work closely with WRO to promote, stage and further develop this global competition that attracts tens of thousands of young people.

As part of its involvement in the competition, Juniper will be sponsoring a new trophy at this year's finals, WRO 2018, known as the Juniper Networks' Engineering Simplicity Honors Award. Juniper will judge teams in the Regular category at the finals, across all age groups, on the boldness, creativity and simplicity of their robot-led solutions. Overall, the WRO competition encourages participating teams to solve challenges and complex problems using mathematics, computer programming and coding skills, as well as exploring the principles of automation. It also fosters other important life skills including teamwork, perseverance, learning from mistakes and creative thinking.

Juniper is currently sponsoring a short documentary film looking at the human stories behind some of the teams and their paths to WRO 2018. The company is working in conjunction with the accomplished filmmaker and director James Redford, who is renowned for making documentary films that focus on personal, solution-based stories addressing vexing social and environmental challenges.

News Highlights:

  • Each year, at least 23,000 teams from more than 70 countries take part in WRO's competition. This involves approximately 100,000 young people, ranging from six to 25 years old.
  • The competition comprises several categories across the age group span, including Regular (a themed category), Open (to drive innovation and creativity), a robotic football tournament, an Advanced Robotics Challenge for students aged 19-25, and WeDo, a starter class for children aged 6-10.
  • Country heats roll up to a national final, with the winners going forward to the global finals.
  • The competition focuses on a specific theme that is relevant to a prevailing global issue - this year it is Food Matters. Challenges are tailored specifically to the theme, enabling competitors to develop ambitious, yet simple, automated solutions.
  • WRO, founded in 2004, hosts the Finals in a different country each year. In 2018, the global finals will be in Chiang Mai, Thailand (November 16-18) and they will take place in Hungary in 2019.

Supporting Quotes

"In WRO, we see robotics as a wonderful platform for giving young people around the world an opportunity to be hands-on with STEM. We see the teams adopt new technology when developing fully autonomous robots and they apply engineering processes when designing prototypes before completing the challenges. They quickly get absorbed in coming up with original solutions to complex problems.

"Bringing Juniper Networks on board as a global premium partner enables us to tap into its heritage and experience as an engineering and automation pioneer. Juniper will provide practical support and inspiration for young people as they embark upon their STEM-driven journeys toward fulfilling careers."
- Claus Ditlev Christensen, secretary-general at World Robot Olympiad Association Ltd.

"My work is all about finding and telling inspiring stories that show the best in people. When I heard about WRO's competition from Juniper, the talent, passion and commitment of so many young people truly excited me. Many teams come from challenging backgrounds with less-than-ideal education provision, so their achievements are all the more impressive. It is also great to be working with a technology innovator like Juniper to help the next generation think about their STEM education in such a creative way."
- James Redford, film and documentary maker

"In the digital age, networks are the lifeblood of every community, every government and every economy. Automation has become a key enabler of such technology, functioning alongside humans to create and operate networks that can scale, flex and protect, dynamically adapting in nanoseconds to deliver rich services. Ironically, a pressing shortage of skilled technologists is likely to increase even more in the future, putting at risk the potential of intelligent networks.

"It is imperative that the upcoming generations understand the importance of automation - Artificial Intelligence, Machine Learning, virtualization - in order to take technology forward into their future. Juniper Networks is proud to be the global technology partner of the WRO Finals in 2018 and beyond, as it is the perfect nurturing environment for tomorrow's automation innovators."
- Mike Marcellin, chief marketing officer at Juniper Networks

Additional Resources: 

About Juniper Networks
Juniper Networks simplifies the complexities of networking with products, solutions and services in the cloud era to transform the way we connect, work and live. We remove the traditional constraints of networking to enable our customers and partners to deliver automated, scalable and secure networks that connect the world. Additional information can be found at Juniper Networks (www.juniper.net) or connect with Juniper on TwitterLinkedIn and Facebook.

Juniper Networks, the Juniper Networks logo and Junos are registered trademarks of Juniper Networks, Inc. and/or its affiliates in the United States and other countries. Other names may be trademarks of their respective owners.

Media Relations
Penny Still
Juniper Networks
Tel: +44 (0) 1372 385 692
Email: pstill@juniper.net




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Juniper Networks via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Arcoma AB: Arcoma presenterar på Redeye Life Science Day den 21:a november16.11.2018 12:53Pressmeddelande

16 November Den 21 november presenterar Jesper Söderqvist, VD på Arcoma, den senaste utvecklingen i Arcoma på Haymarket by Scandic i Stockholm. Presentationen "Arcoma, ett tillväxtbolag i en växande marknad" hålls klockan 13:00 och kan följas i livesändning på redeye.se/live/lsday-2018. Presentationen kommer även i efterhand att finnas tillgänglig på www.redeye.se/live/ls-day-2018 samt på Bolagets sida i Redeye Universe (redeye.se/company/Arcoma) Om Arcoma Arcoma, med lång erfarenhet av branschen, är en ledande leverantör av integrerade digitala röntgensystem med hög kvalitet och avancerad teknik. Arcomas produkter erbjuder den senaste digitala bildtekniken kombinerat med tekniskt avancerade rörliga positioneringssystem, vilket tillsammans med ergonomisk skandinavisk design, erbjuder kunden kompletta, konfigurerbara och funktionella digitala röntgensystem. Bolagets produkter säljs via återförsäljare samt via OEM-kunder och det finns idag över 3 500 av Arcomas röntgensystem installerade

Iconovo: kundprojekt blir framflyttat tre till sex månader8.11.2018 15:45Pressmeddelande

Fortsatt arbete med ett av Iconovos pågående kundprojekt kommer att flyttas fram tre till sex månader. Projektet avser utveckling av produkt anpassad för kund som ska svara för produktion och marknadslansering. Det aktuella arbetet var planerat att ske under fjärde kvartalet men beräknas ske under nästa år, och detta påverkar Iconovos omsättning under 2018 negativt med cirka 2 miljoner kronor. Orsaken är att kunden har beslutat att genomföra en mindre klinisk studie för att verifiera produkten innan nästa steg tas vilken omfattar investeringar i betydande mångmiljonbelopp i produktionskapacitet, baserat på Iconovos utveckling. Studien görs för kundens egna räkning och är inte villkorad av tillsynsmyndigheter. "Detta påverkar vårt resultat på kort sikt, men det faktum att kunden har beslutat att göra en betydande investering i faktisk produktion betyder att vi med stor säkerhet kan se fram emot licensintäkter under en lång tidsrymd framöver i samband med att produkten lanseras på markna

Stillfront Group AB: Inbjudan till Stillfront Groups kvartalsrapport för tredje kvartalet 20187.11.2018 14:34Pressmeddelande

PRESSMEDDELANDE 7 november 2018 Inbjudan till Stillfront Groups kvartalsrapport för tredje kvartalet 2018 Stillfront Groups kvartalsrapport för det tredje kvartalet 2018 kommer att publiceras klockan 07.00 den 22 november 2018. En webbsänd telefonkonferens kommer att hållas klockan 10.00 samma dag där Jörgen Larsson, VD och Sten Wranne, CFO, kommenterar resultatet. Presentationen och rapporten kommer efter presentationen att finnas tillgänglig på www.stillfront.com Webbsändningen nås på adressen: https://tv.streamfabriken.com/stillfront-q3-2018 För att delta via telefon, vänligen ring: SE: +46 8 566 426 63 UK: +44 20 300 898 01 US: +1 8 557 532 235 FÖR YTTERLIGARE INFORMATION, VÄNLIGEN KONTAKTA: Sofia Wretman, IR Phone: +46 708 11 64 30 sofia@stillfront.com OM STILLFRONT Stillfront är en oberoende utvecklare, förläggare och distributör av digitala spel - med visionen att bli en ledande indie-spelutvecklare och förläggare. Stillfront är verksamt genom tio näst intill självständiga dotte

Stillfront Group AB: Invitation to Stillfront Group Q3 presentation7.11.2018 14:34Pressmeddelande

Invitation to Stillfront Group Q3 presentation Stillfront Group interim report for the third quarter 2018 will be published at 07.00 CET on 22 November 2018. A presentation of the report will be held the same day at 10.00 CET via telephone conference or audiocast where Jörgen Larsson, CEO and CFO Sten Wranne are to comment on the report. The presentation can be viewed live at https://tv.streamfabriken.com/stillfront-q3-2018 To participate via phone please call: SE: +46 8 566 426 63 UK: +44 20 300 898 01 US: +1 8 557 532 235 FOR FURTHER INFORMATION, PLEASE CONTACT: Sofia Wretman, IR Phone: +46 708 11 64 30 sofia@stillfront.com ABOUT STILLFRONT Stillfront is a group of independent creators, publishers and distributors of digital games - with a vision to become the leading group of indie game creators and publishers. Stillfront operates through ten near-autonomous subsidiaries: Bytro Labs in Germany, Coldwood Interactive in Sweden, Power Challenge in the UK and Sweden, Dorado Online Games

Modus Therapeutics announces FDA Acceptance of Sevuparin IND for the treatment of sickle cell disease7.11.2018 08:30Pressmeddelande

STOCKHOLM, November 7, 2018. Karolinska Development's portfolio company Modus Therapeutics announces today that the U.S Food & Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application to initiate a Phase I clinical trial with subcutaneous sevuparin for the treatment of sickle cell disease (SCD) FDA has decided to accept Modus Therapeutics' IND application of sevuparin for the treatment of SCD. Sevuparin is an innovative, proprietary modified polysaccharide drug with anti-adhesive, anti-aggregate and anti-inflammatory effects due to its multimodal mechanism of action. It has the potential to restore blood flow and prevent further microvascular obstructions in children and adults with SCD. At present, sevuparin is being evaluated as an intravenous infusion in a Phase II study in SCD patients with ongoing painful crises (also called vaso occlusive crises, VOC). In order to broaden the clinical scope and utility of sevuparin in the treatment of SCD, t

Modus Therapeutics announces FDA Acceptance of Sevuparin IND for the treatment of sickle cell disease7.11.2018 08:30Pressmeddelande

STOCKHOLM, November 7, 2018. Karolinska Development's portfolio company Modus Therapeutics announces today that the U.S Food & Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application to initiate a Phase I clinical trial with subcutaneous sevuparin for the treatment of sickle cell disease (SCD) FDA has decided to accept Modus Therapeutics' IND application of sevuparin for the treatment of SCD. Sevuparin is an innovative, proprietary modified polysaccharide drug with anti-adhesive, anti-aggregate and anti-inflammatory effects due to its multimodal mechanism of action. It has the potential to restore blood flow and prevent further microvascular obstructions in children and adults with SCD. At present, sevuparin is being evaluated as an intravenous infusion in a Phase II study in SCD patients with ongoing painful crises (also called vaso occlusive crises, VOC). In order to broaden the clinical scope and utility of sevuparin in the treatment of SCD, t

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum